Clinical Trials Browser

Completed × N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide × Clear all

NCT05991973 2025-12-05

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Phase 2 Completed

Lymphoma

NCT05632848 2025-07-21

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

Phase 2 Completed

Triple Negative Breast Neoplasms

NCT05068427 2024-08-07

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT04465097 2023-10-17

NeoTEE

Phase 2 Completed

Breast Neoplasms

NCT04022005 2023-09-11

Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCL

Phase 2 Completed

Lymphoma, Large B-Cell, Diffuse

NCT03974243 2022-03-09

Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma

Phase 1/2 Completed

Lymphoma, Non-Hodgkin

NCT02482753 2022-01-12

Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT02809573 2019-07-24

Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

Phase 1 Completed

Lymphoma, T-Cell, Peripheral

NCT02697552 2017-01-12

Safety Study of HBI-8000 in Japanese Patients With Non Hodgkin's Lymphoma

Phase 1 Completed

Lymphoma, Non-Hodgkin

NCT01836679 2016-02-01

Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung